First Time Loading...

Shattuck Labs Inc
NASDAQ:STTK

Watchlist Manager
Shattuck Labs Inc Logo
Shattuck Labs Inc
NASDAQ:STTK
Watchlist
Price: 9.9 USD 4.32% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. [ Read More ]

The intrinsic value of one STTK stock under the Base Case scenario is 0.63 USD. Compared to the current market price of 9.9 USD, Shattuck Labs Inc is Overvalued by 94%.

Key Points:
STTK Intrinsic Value
Base Case
0.63 USD
Overvaluation 94%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Shattuck Labs Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling STTK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Shattuck Labs Inc

Provide an overview of the primary business activities
of Shattuck Labs Inc.

What unique competitive advantages
does Shattuck Labs Inc hold over its rivals?

What risks and challenges
does Shattuck Labs Inc face in the near future?

Has there been any significant insider trading activity
in Shattuck Labs Inc recently?

Summarize the latest earnings call
of Shattuck Labs Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shattuck Labs Inc.

Provide P/S
for Shattuck Labs Inc.

Provide P/E
for Shattuck Labs Inc.

Provide P/OCF
for Shattuck Labs Inc.

Provide P/FCFE
for Shattuck Labs Inc.

Provide P/B
for Shattuck Labs Inc.

Provide EV/S
for Shattuck Labs Inc.

Provide EV/GP
for Shattuck Labs Inc.

Provide EV/EBITDA
for Shattuck Labs Inc.

Provide EV/EBIT
for Shattuck Labs Inc.

Provide EV/OCF
for Shattuck Labs Inc.

Provide EV/FCFF
for Shattuck Labs Inc.

Provide EV/IC
for Shattuck Labs Inc.

Show me price targets
for Shattuck Labs Inc made by professional analysts.

What are the Revenue projections
for Shattuck Labs Inc?

How accurate were the past Revenue estimates
for Shattuck Labs Inc?

What are the Net Income projections
for Shattuck Labs Inc?

How accurate were the past Net Income estimates
for Shattuck Labs Inc?

What are the EPS projections
for Shattuck Labs Inc?

How accurate were the past EPS estimates
for Shattuck Labs Inc?

What are the EBIT projections
for Shattuck Labs Inc?

How accurate were the past EBIT estimates
for Shattuck Labs Inc?

Compare the revenue forecasts
for Shattuck Labs Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shattuck Labs Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shattuck Labs Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shattuck Labs Inc compared to its peers.

Compare the P/E ratios
of Shattuck Labs Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Shattuck Labs Inc with its peers.

Analyze the financial leverage
of Shattuck Labs Inc compared to its main competitors.

Show all profitability ratios
for Shattuck Labs Inc.

Provide ROE
for Shattuck Labs Inc.

Provide ROA
for Shattuck Labs Inc.

Provide ROIC
for Shattuck Labs Inc.

Provide ROCE
for Shattuck Labs Inc.

Provide Gross Margin
for Shattuck Labs Inc.

Provide Operating Margin
for Shattuck Labs Inc.

Provide Net Margin
for Shattuck Labs Inc.

Provide FCF Margin
for Shattuck Labs Inc.

Show all solvency ratios
for Shattuck Labs Inc.

Provide D/E Ratio
for Shattuck Labs Inc.

Provide D/A Ratio
for Shattuck Labs Inc.

Provide Interest Coverage Ratio
for Shattuck Labs Inc.

Provide Altman Z-Score Ratio
for Shattuck Labs Inc.

Provide Quick Ratio
for Shattuck Labs Inc.

Provide Current Ratio
for Shattuck Labs Inc.

Provide Cash Ratio
for Shattuck Labs Inc.

What is the historical Revenue growth
over the last 5 years for Shattuck Labs Inc?

What is the historical Net Income growth
over the last 5 years for Shattuck Labs Inc?

What is the current Free Cash Flow
of Shattuck Labs Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shattuck Labs Inc.

Financials

Balance Sheet Decomposition
Shattuck Labs Inc

Current Assets 143.2m
Cash & Short-Term Investments 130.6m
Other Current Assets 12.6m
Non-Current Assets 16.3m
PP&E 16.1m
Other Non-Current Assets 269k
Current Liabilities 11.5m
Accounts Payable 1.6m
Accrued Liabilities 9.9m
Non-Current Liabilities 3.4m
Other Non-Current Liabilities 3.4m
Efficiency

Earnings Waterfall
Shattuck Labs Inc

Revenue
1.7m USD
Operating Expenses
-93.3m USD
Operating Income
-91.7m USD
Other Expenses
4.4m USD
Net Income
-87.3m USD

Free Cash Flow Analysis
Shattuck Labs Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

STTK Profitability Score
Profitability Due Diligence

Shattuck Labs Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Exceptional 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
Negative ROE
21/100
Profitability
Score

Shattuck Labs Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

STTK Solvency Score
Solvency Due Diligence

Shattuck Labs Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Shattuck Labs Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STTK Price Targets Summary
Shattuck Labs Inc

Wall Street analysts forecast STTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STTK is 11.9 USD with a low forecast of 11.11 USD and a high forecast of 12.6 USD.

Lowest
Price Target
11.11 USD
12% Upside
Average
Price Target
11.9 USD
20% Upside
Highest
Price Target
12.6 USD
27% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

STTK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

STTK Price
Shattuck Labs Inc

1M 1M
+8%
6M 6M
+515%
1Y 1Y
+241%
3Y 3Y
-70%
5Y 5Y
-42%
10Y 10Y
-42%
Annual Price Range
9.9
52w Low
1.37
52w High
10.13
Price Metrics
Average Annual Return 4.28%
Standard Deviation of Annual Returns 139.25%
Max Drawdown -98%
Shares Statistics
Market Capitalization 467.9m USD
Shares Outstanding 47 474 800
Percentage of Shares Shorted 5.6%

STTK Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Shattuck Labs Inc Logo
Shattuck Labs Inc

Country

United States of America

Industry

Biotechnology

Market Cap

467.9m USD

Dividend Yield

0%

Description

Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. The company is headquartered in Austin, Texas and currently employs 85 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of dual-sided fusion proteins. The firm has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected Checkpoint (ARC) platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the cluster of differentiation 47/signal regulatory protein alpha (CD47/SIRPa) checkpoint interaction to restore an anti-tumor immune response and to activate the cluster of differentiation 40 (CD40) costimulatory receptor to bolster an immune response. The firm's second product candidate, SL-279252, is designed to simultaneously inhibit the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction and activate the OX40 receptor.

Contact

TEXAS
Austin
500 W. 5Th Street, Suite 100
+15129004690.0
https://www.shattucklabs.com/

IPO

2020-10-09

Employees

85

Officers

Co-Founder, CEO & Director
Dr. Taylor H. Schreiber M.D., Ph.D.
Chief Technical Officer
Dr. Abhinav A. Shukla Ph.D.
Chief Medical Officer
Dr. Arundathy Nirmalini Pandite M.B.A., M.D.
Chief Financial Officer
Mr. Andrew R. Neill M.B.A.
Vice President of Investor Relations
Mr. Conor Richardson CPA
General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer
Dr. Stephen Stout J.D., Ph.D.
Show More
Chief Business Officer
Ms. Casi DeYoung
Senior Vice President of Regulatory Affairs
Dr. Thomas Lampkin Pharm.D.
Chief Scientific Officer of ARC Platform
Mr. George Fromm Ph.D.
Chief Scientific Officer of GADLEN Platform
Mr. Suresh de Silva Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one STTK stock?

The intrinsic value of one STTK stock under the Base Case scenario is 0.63 USD.

Is STTK stock undervalued or overvalued?

Compared to the current market price of 9.9 USD, Shattuck Labs Inc is Overvalued by 94%.